These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


451 related items for PubMed ID: 7863757

  • 1. Immunoprecipitation of mycobacterial antigens with sera from patients with leprosy.
    Kode JA, Chiplunkar SV, Samson PD, Deo MG, Gangal SG.
    Acta Leprol; 1994; 9(2):89-94. PubMed ID: 7863757
    [Abstract] [Full Text] [Related]

  • 2. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
    Ottenhoff TH, Converse PJ, Gebre N, Wondimu A, Ehrenberg JP, Kiessling R.
    Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
    [Abstract] [Full Text] [Related]

  • 3. Sero-immunoreactivity of cloned protein antigens of Mycobacterium leprae.
    Khan MB, Deshpande RG, Davidson SK, Navalkar RG.
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):195-200. PubMed ID: 1522362
    [Abstract] [Full Text] [Related]

  • 4. Major proteins of mycobacterial strain ICRC and Mycobacterium leprae, identified by antibodies in sera from leprosy patients and their contacts.
    Chiplunkar SV, Kudalkar JL, Butlin R, Samson PD, Deo MG, Gangal SG.
    J Clin Microbiol; 1992 Feb; 30(2):336-41. PubMed ID: 1537902
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antibody response to recombinant 65-kDa, 70-kDa and 18-kDa mycobacterial antigens in leprosy patients and healthy contacts in a leprosy-endemic population.
    Ilangumaran S, Shankernarayan N, Ramu G, Muthukkaruppan V.
    Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):245-55. PubMed ID: 7519226
    [Abstract] [Full Text] [Related]

  • 7. Antigens of Mycobacterium leprae identified by immunoprecipitation with sera from leprosy and tuberculosis patients.
    Britton WJ, Hellqvist L, Garsia RJ, Basten A.
    Clin Exp Immunol; 1988 Mar; 71(3):394-8. PubMed ID: 3289801
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cross-reactivity of anti-10kD heat shock protein antibodies in leprosy and tuberculosis patients.
    Rojas RE, Demichelis SO, Giménez MF, Molinari ML, Segal-Eiras A.
    Medicina (B Aires); 1997 Mar; 57(5):581-6. PubMed ID: 9674227
    [Abstract] [Full Text] [Related]

  • 13. Mycobacterial antigens in antibody responses of leprosy patients.
    Kronvall G, Bjune G, Stanford J, Menzel S, Samuel D.
    Int J Lepr Other Mycobact Dis; 1975 Mar; 43(4):306. PubMed ID: 58844
    [Abstract] [Full Text] [Related]

  • 14. Comparison of 22 species of Mycobacteria by immunodiffusion against an absorbed reference leprosy serum.
    Gillis TP, Abe M, Bullock WE, Rojas-Espinosa O, Garcia-Ortigoza E, Draper P, Kirchheimer W, Buchanan TM.
    Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):287-93. PubMed ID: 6172393
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Identification of a Mycobacterium leprae specific protein antigen(s) and its possible application for the serodiagnosis of leprosy.
    Caldwell HD, Kirchheimer WF, Buchanan TM.
    Int J Lepr Other Mycobact Dis; 1979 Sep; 47(3):477-83. PubMed ID: 90666
    [Abstract] [Full Text] [Related]

  • 20. HLA and leprosy in the pre and postgenomic eras.
    Geluk A, Ottenhoff TH.
    Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.